Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
Clinical trial NCT06735690 · RECRUITING
Trial details
- NCT number
- NCT06735690
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2029-03-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.